Introduction. Materials and methods
|
|
- Ada Carson
- 5 years ago
- Views:
Transcription
1 Journal of Antimicrobial Chemotherapy (2002) 49, JAC Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis Juan P. Horcajada a *, Jordi Vila b, Antonio Moreno-Martínez a, Joaquim Ruiz b, Jose Antonio Martínez a, Miquel Sánchez c, Eladio Soriano a and Josep Mensa a Departments of a Infectious Diseases and b Microbiology, Institut Clínic d Infeccions i Immunologia (ICII) and c Department of Internal Medicine, Hospital Clínic Universitari, Villarroel 170, Barcelona, Spain The emergence and evolution of quinolone-resistant Escherichia coli in faeces of patients with prostatitis treated with high-dose oral ciprofloxacin for 1 month were studied. In 11 of 23 patients, from whom only quinolone-susceptible E. coli was isolated before treatment, quinolone-resistant strains, genetically distinct from the quinolone-susceptible ones, predominated during and just after therapy. Two months after treatment, these were completely displaced by quinolone-susceptible E. coli, genetically distinct from the E. coli isolated before and during therapy. Hence, during ciprofloxacin therapy, half of the patients were transiently colonized with new, quinolone-resistant strains of E. coli. Introduction The wide use of fluoroquinolones in both human and animal medicine has led to a significant increase in the level of resistance to these antimicrobial agents in clinical isolates of Escherichia coli from several geographical areas. 1 4 Patients receiving fluoroquinolones for long periods, either to prevent recurrent urinary tract infections or for selective intestinal decontamination, may be colonized by quinolone-resistant Enterobacteriaceae in the intestinal tract. 5 7 However, neither the origin of these resistant strains nor the evolution of intestinal colonization after the selective pressure exerted by the quinolones is removed has been studied. The resistant strains could be newly acquired exogenous resistant strains or resistant mutants arising from strains already in the intestinal tract. The selection of quinolone-resistant mutants correlates with ratios of the selective concentration of quinolone and MIC 8 mg/l. The use of fluoroquinolones with little intrinsic activity, the prescription of relatively low doses, such as in the course of prophylaxis of urinary tract infections, and the partial inactivation of fluoroquinolones in stools, are conditions that determine concentration/mic ratio and, therefore, favour the selection of resistant mutants. In contrast, selection of resistant mutants is likely to be less frequent if the patient is prescribed ciprofloxacin at therapeutic doses. 8 The main objectives of this study were: (i) to analyse the evolution of the susceptibility to fluoroquinolones of E. coli strains isolated from faecal flora during and after the administration of therapeutic doses of oral ciprofloxacin for 1 month; (ii) to investigate whether there is any relationship between the resistant strains isolated during treatment and susceptible strains in the gut before treatment. Materials and methods Patients The study involved 29 outpatients with acute prostatitis for whom the initial faecal sample was positive for E. coli and who attended the Infectious Disease Department of the Hospital Clínic (Barcelona, Spain), a 900 bed tertiary hospital. These patients were treated orally with ciprofloxacin 750 mg twice daily for 28 days. Compliance with prescribed treatment was monitored by means of a pill count of returned boxes of antibiotic and by interview. None of the patients had received antibiotics for at least 4 weeks before the study commenced. *Corresponding author. Tel: ; Fax: ; jhorcaja@clinic.ub.es 2002 The British Society for Antimicrobial Chemotherapy 55
2 J. P. Horcajada et al. Microbiological methods Stool cultures were collected immediately before therapy commenced and every 2 weeks during and after treatment, until a predominant quinolone-susceptible E. coli strain was isolated. Fresh stools were collected in sterile containers and cultured immediately. One gram of faeces was homogenized in 9 ml of saline serum and plated by streaking 0.05 ml on to MacConkey agar. After inoculation, plates were incubated aerobically at C for 2 days. To recover the predominant E. coli strains, all morphologically different colonies suspected to be E. coli were subcultured in the same medium and identified by conventional methods. E. coli isolates were then stored in skimmed milk at 70 C, until antibiotic susceptibility tests and molecular studies were performed. Antimicrobial susceptibility tests Antibiotic susceptibility testing was performed by the Etest method (AB Biodisk, Solna, Sweden) following the manufacturer s instructions. E. coli ATCC was used as the quality control organism. DNA sequencer (Applied Biosystems 377; Perkin-Elmer, Foster City, CA, USA). When the PCR product from the QRDR of the gyra gene was analysed by digestion with HinfI, 20 L of PCR mixture were incubated for 2.5 h with 10 U of restriction endonuclease. Digestion products were separated by electrophoresis in NuSieve (1.5% w/v) and agarose (1% w/v) gels. Results Before ciprofloxacin administration, the predominant E. coli strains in the faecal flora were susceptible to quinolones in 23 (79%) of 29 patients studied (patients 1 23 in Table). In the remaining six patients (21%), the initial strains were resistant to nalidixic acid (patients in the Table and the Figure) and four of these were also resistant to ciprofloxacin (patients 24 27). For 12 (52%) of the 23 patients with quinolone-susceptible E. coli strains at the start of treatment, no growth of E. coli was observed from stool cultures made during treatment, whereas for each of the remaining 11 patients (48%) a quinolone-resistant strain was isolated during treatment Epidemiological analysis The epidemiological relationships among the E. coli strains isolated at different times from each patient were determined by repetitive extragenic palindromic PCR (REP- PCR). For REP-PCR, bacteria were grown on MacConkey agar overnight and one colony of each isolate was suspended in 25 L of reaction mixture containing 20 mm Tris HCl ph 8.8, 100 mm KCl, 3.0 mm MgCl 2, gelatin 0.1% (v/v) and 400 M dntps. Primer was added at 1 M, together with 2.5 U Taq polymerase. The reaction mixture was overlaid with mineral oil and DNA amplification was achieved with the following programme: 30 cycles of 94 C for 1 min, 40 C for 1 min and 65 C for 8 min, with a single final extension at 65 C for 16 min. Samples (10 L) of each PCR end-product were analysed on agarose (1.5% w/v) gels. The primer used was 5 -GCGCCGICATGCGGC- ATT-3. Detection of mutations in the gyra gene To study the mechanisms of quinolone resistance in the strains isolated, PCR amplification and DNA sequencing of the quinolone resistance determining region (QRDR) of the gyra gene were performed as described elsewhere. 9 PCRs were carried out in a DNA Thermal Cycler 480 (Perkin-Elmer Cetus, Emeryville, CA, USA). Primers and free nucleotides were removed with a QiaQuick spin PCR purification kit (Qiagen, Inc., Chatsworth, CA, USA), according to the manufacturer s instructions; the sample was directly processed for DNA sequencing with Thermo Sequenase II Dye Terminator cycle sequencing kit (Amersham, Cleveland, OH, USA) and analysed in an automatic Figure. REP-PCR patterns. Patient 24: lane 1, quinoloneresistant E. coli before treatment; lane 2, quinolone-resistant E. coli with the same REP-PCR pattern during treatment; lane 3, quinolone-susceptible E. coli with different REP-PCR pattern after treatment. Patient 13: lane 1, quinolone-susceptible E. coli before treatment; lane 2, quinolone-resistant E. coli with different REP-PCR pattern during treatment; lane 3, quinolone-susceptible E. coli with different REP-PCR pattern after treatment. Patient 1: lane 1, quinolone-susceptible E. coli before treatment; lane 2, quinolone-susceptible E. coli with different REP-PCR pattern after treatment. Lane M, DNA molecular weight markers (Gibco-BRL). 56
3 Epidemiology of E. coli quinolone resistance Table. Evolution of susceptibility to quinolones and molecular epidemiology of the E. coli isolates Before treatment During treatment a 1st month after treatment 2nd month after treatment Patient no. MIC NAL MIC CIP MIC NAL MIC CIP clonal identity b MIC NAL MIC CIP clonal identity b MIC NAL MIC CIP clonal identity b NBG NBG NBG no NBG NBG NBG no NBG NBG NBG NBG NBG NBG no NBG NBG NBG NBG NBG NBG no NBG NBG NBG NBG NBG NBG no NBG NBG NBG NBG NBG NBG no NBG NBG NBG NBG NBG NBG no NBG NBG NBG NBG NBG NBG no NBG NBG NBG NBG NBG NBG no NBG NBG NBG NBG NBG NBG no NBG NBG NBG NBG NBG NBG no NBG NBG NBG NBG NBG NBG no >256 >32 no no >256 >32 no no >256 >32 no >256 3 no no >256 >32 no >256 >32 no no NBG NBG NBG >256 >32 no no NBG NBG NBG >256 >32 no no NBG NBG NBG > no no NBG NBG NBG >256 >32 no no NBG NBG NBG >256 >32 no no NBG NBG NBG > no no >256 8 no NBG NBG NBG no 24 >256 >32 >256 >32 yes no 25 >256 >32 >256 >32 yes no 26 >256 >32 NBG NBG NBG >256 >32 yes no 27 >256 >32 >256 >32 yes >256 >32 yes no 28 > >256 >32 no NBG NBG NBG no 29 > NBG NBG NBG > no no MIC NAL, MIC of nalidixic acid (mg/l). MIC CIP, MIC of ciprofloxacin (mg/l). NBG, no bacterial growth. a Ciprofloxacin 750 mg bd po for 28 days. b Clonal identity with the strain isolated immediately before. 57
4 J. P. Horcajada et al. or from the first stool culture performed 15 days after treatment finished (patients in the Table and the Figure). The MICs of nalidixic acid for these 11 strains were 256 mg/l and the MICs of ciprofloxacin were 32 mg/l in eight (72%) of the 11 strains. All the quinolone-resistant strains were genetically different from the quinolonesusceptible strains recovered before starting quinolone treatment. The four patients whose strains were initially resistant to nalidixic acid and ciprofloxacin harboured the same strains during treatment (patients in the Table and the Figure). In the two patients whose strains at the start of the study were resistant only to nalidixc acid, quinoloneresistant but genetically different strains were isolated during or just after treatment (patients 28 and 29 in the Table). Within 2 months of the end of quinolone treatment, the predominant E. coli strains in the faecal flora of all patients were susceptible to quinolones (nalidixic acid MIC 4 mg/l, ciprofloxacin MIC 0.02 mg/l) and genetically different from both the quinolone-susceptible strains isolated before treatment and from the quinolone-resistant strains isolated during treatment (Table and Figure). All the quinolone-resistant strains showed at least one mutation, specifically in the triplet encoding amino acid residue Ser-83 of GyrA. Discussion The study illustrates the dynamics of the predominant E. coli faecal flora in 29 males with prostatitis given highdose oral ciprofloxacin therapy. Before treatment the predominant E. coli strains were susceptible to nalidixic acid and ciprofloxacin in 23 (79%) and 26 (90%) patients, respectively. During or shortly after therapy of these patients, the dominant quinolone-susceptible E. coli strains were no longer detected; in eight cases they were substituted by genetically unrelated strains resistant to ciprofloxacin; in three patients new strains, resistant to nalidixic acid but susceptible to ciprofloxacin, emerged. In the remaining four patients where the dominant pretherapy E. coli strains were resistant to ciprofloxacin, the same organisms persisted during therapy and for a short time thereafter. Finally, after ciprofloxacin therapy ceased, all patients acquired new quinolone-susceptible E. coli that were genetically unrelated to previous isolates, as the dominant strains. Since our method only detected the dominant faecal E. coli strain in each patient, it can only be asserted with certainty that high-dose oral ciprofloxacin did not select resistant mutants from the susceptible strain detected initially. The origin of the resistant E. coli that emerged during treatment cannot be determined from the current data. Three scenarios are conceivable: (i) unmasking of ciprofloxacin-resistant organisms present in low numbers before therapy but undetected by the methodology; (ii) acquisition of an exogenous resistant strain during treatment; and (iii) selection in the host of highly resistant mutants from pre-existing intermediately susceptible organisms. In the particular setting, either of the first two possibilities is likely, considering that the use of quinolones in the community is widespread and that resistant strains selected in food animals exposed to quinolones may have been introduced into the food chain. 2 4 We included in the study only patients who had not taken antibiotics during the month before taking the first sample, but we did not investigate the issue further. The presence of high-level quinolone-resistant E. coli strains in four of our patients at baseline could indicate previous exposure to quinolones. High rates of faecal carriage of quinolone-resistant E. coli strains in healthy people in our community and an extremely high prevalence of quinolone-resistant E. coli in the stools of farm animals in our geographical area have been reported. 4 These data are consistent with the hypothesis that the resistant E. coli strains found in our patients were either already carried in low numbers before therapy or were acquired during ciprofloxacin administration. The possibility that high-level resistance was selected by ciprofloxacin from pre-existing intermediate-susceptible strains seems less likely, since in two patients, where the predominant strain was one with a single Ser-83 mutation before treatment, high-dose oral ciprofloxacin therapy simply suppressed its growth without selecting mutants with increased resistance. The transient nature of the faecal carriage of high-level quinolone-resistant E. coli strains after ciprofloxacin therapy has been reported in neutropenic patients, but no information was given about the molecular epidemiology of the successive isolates. 10 It seems probable that susceptible E. coli strains, in the absence of selective antibiotic pressure, are more fit than resistant ones, and replace them. With our methodology we could not discern whether the resistant strains disappeared completely, or remained at low density together with the quinolone-susceptible strains. Studies are in progress to clarify this issue. Acknowledgements The competent assistance of Victoria Lasheras is gratefully acknowledged. This work was supported, in part, by grant SAF 97/0091 from Plan Nacional I D, Spain and Beca Agustí Pumarola from the Societat Catalana de Malalties Infeccioses. References 1. Cometta, A., Calandra, T., Bille, J. & Glauser, P. (1994). Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia. New England Journal of Medicine 330, Ena, J., Lopez-Perezagua, M. M., Martinez-Peinado, C., Cia- Barrio, M. A. & Ruiz-Lopez, I. (1998). Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoro- 58
5 Epidemiology of E. coli quinolone resistance quinolones. Diagnostic Microbiology and Infectious Disease 30, Blanco, J. E., Blanco, M., Mora, A. & Blanco, J. (1997). Prevalence of bacterial resistance to quinolones and other antimicrobials among avian Escherichia coli strains isolated from septicemic and healthy chickens in Spain. Journal of Clinical Microbiology 35, Garau, J., Xercavins, M., Rodríguez-Carballeira, M., Gómez- Vera, J. R., Coll, I., Vidal, D. et al. (1999). Emergence and dissemination of quinolone-resistant Escherichia coli in the community. Antimicrobial Agents and Chemotherapy 43, Carratala, J., Fernandez-Sevilla, A., Tubau, F., Dominguez, M. A. & Gudiol, F. (1996). Emergence of fluoroquinolone-resistant Escherichia coli in faecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrobial Agents and Chemotherapy 40, Dupeyron, C., Mangeney, N., Sedrati, L., Campillo, B., Fouet, P. & Leluan, G. (1994). Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis. Antimicrobial Agents and Chemotherapy 38, Novella, M., Sola, R., Soriano, G., Andreu, M., Gana, J., Ortiz, J. et al. (1997). Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 25, Daikos, G. L., Kathpalia, S. B., Sharifi, R., Lolans, V. T. & Jackson, G. G. (1997). Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of faecal flora. American Journal of Medicine 82, Suppl. 4A, Tavío, M. M., Vila, J., Ruiz, J., Ruiz, J., Martín-Sánchez, A. M. & Jiménez de Anta, M. T. (1999). Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli strains. Journal of Antimicrobial Chemotherapy 44, Perea, S., Hidalgo, M., Arcediano A., Ramos, M. J., Gomez, C., Hornedo, J. et al. (1999). Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis. Journal of Antimicrobial Chemotherapy 44, Received 20 November 2000; returned 20 March 2001; revised 15 May 2001; accepted 4 September
6
Presence of extended spectrum β-lactamase producing Escherichia coli in
1 2 Presence of extended spectrum β-lactamase producing Escherichia coli in wild geese 3 4 5 A. Garmyn* 1, F. Haesebrouck 1, T. Hellebuyck 1, A. Smet 1, F. Pasmans 1, P. Butaye 2, A. Martel 1 6 7 8 9 10
More informationAbstract. Introduction
Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis Yong Chong 1 *, Shinji Shimoda 1, Hiroko Yakushiji
More informationA retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya
A retrospective analysis of urine culture results issued by the microbiology department, Teaching Hospital, Karapitiya LU Edirisinghe 1, D Vidanagama 2 1 Senior Registrar in Medicine, 2 Consultant Microbiologist,
More informationChristiane Gaudreau* and Huguette Gilbert
Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationShould we test Clostridium difficile for antimicrobial resistance? by author
Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first
More informationCipro for gram positive cocci in urine
Buscar... Cipro for gram positive cocci in urine 20-6-2017 Pneumonia can be generally defined as an infection of the lung parenchyma, in which consolidation of the affected part and a filling of the alveolar
More informationEffect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms in the intestinal microflora
Journal of Antimicrobial Chemotherapy (2004) 54, 791 797 DOI: 10.1093/jac/dkh406 Advance Access publication 25 August 2004 Effect of Lactobacillus F19 on the emergence of antibioticresistant microorganisms
More informationMili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh
Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original
More informationMRSA surveillance 2014: Poultry
Vicky Jasson MRSA surveillance 2014: Poultry 1. Introduction In the framework of the FASFC surveillance, a surveillance of MRSA in poultry has been executed in order to determine the prevalence and diversity
More informationJAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro
Journal of Antimicrobial Chemotherapy (1997) 39, 713 717 JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro Ian Morrissey* Department of Biosciences, Division of Biochemistry
More informationCipro for klebsiella uti
Cipro for klebsiella uti Search Can UTI be an effective treatment for Klebsiella Pneumoniae? It is safe or dangerous to use UTI while suffering from Klebsiella Pneumoniae? 87 discussions on Treato. instock
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationPCR detection of Leptospira in. stray cat and
PCR detection of Leptospira in 1 Department of Pathology, School of Veterinary Medicine, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran 2 Department of Microbiology, School of Veterinary
More informationAntimicrobial susceptibility testing of Campylobacter jejuni and C. coli
Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Campylobacter Workshop The 7th -8th of Oct. 2008 National Veterinary Institute Uppsala, Sweden Legislation The Commission has
More informationUrban Water Security Research Alliance
Urban Water Security Research Alliance Antibiotic Resistant Bacteria in Hospital Wastewaters and Sewage Treatment Plants Mohammad Katouli Hospital Wastewater Science Forum, 19-20 June 2012 Antibiotic resistance
More informationAntimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb.
Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Training course in AST Copenhagen, Denmark 23-27th Feb. 2009 Methodologies E-test by AB-biodisk A dilution test based on the
More informationProject Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms
Project Summary Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms Principal Investigators: Mindy Brashears, Ph.D., Texas Tech University Guy
More informationQ1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.
Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.
More informationBulgarian Journal of Veterinary Medicine, 2014, 17, No 1, ISSN ; online at
Bulgarian Journal of Veterinary Medicine, 2014, 17, No 1, 25 31 ISSN 1311-1477; online at http://tru.uni-sz.bg/bjvm/bjvm.htm EVIDENCE OF gyra MUTATIONS IN NALIDIXIC ACID- RESISTANT SALMONELLA ENTERICA
More informationECOLOGICAL IMPACT OF NARROW SPECTRUM ANTIMICROBIAL AGENTS COMPARED TO BROAD SPECTRUM AGENTS ON THE HUMAN INTESTINAL MICROFLORA CARL ERIK NORD
Old Herborn University Seminar Monograph 3: Consequences of antimicrobial therapy for the composition of the microflora of the digestive tract. Editors: Carl Erik Nord, Peter J. Heidt, Volker Rusch, and
More informationPrevalence of Ciprofloxacin Resistance Among Gram-Negative Bacilli at a Specialist Hospital in Saudi Arabia
Bangladesh Journal of Medical Science Vol. 11 No. 04 Oct 12 Original article Prevalence of Ciprofloxacin Resistance Among Gram-Negative Bacilli at a Specialist Hospital in Saudi Arabia Ahmad S Abstract:
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062
More informationCommunity-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018
Community-Associated C. difficile Infection: Think Outside the Hospital Maria Bye, MPH Epidemiologist Maria.Bye@state.mn.us 651-201-4085 May 1, 2018 Clostridium difficile Clostridium difficile Clostridium
More informationAntibiotic resistance of bacteria along the food chain: A global challenge for food safety
GREASE Annual Scientific Seminar. NIVR, 17-18th March 2014. Hanoi-Vietnam Antibiotic resistance of bacteria along the food chain: A global challenge for food safety Samira SARTER CIRAD-UMR Qualisud Le
More informationPlease distribute a copy of this information to each provider in your organization.
HEALTH ADVISORY TO: Physicians and other Healthcare Providers Please distribute a copy of this information to each provider in your organization. Questions regarding this information may be directed to
More informationLEVOFLOXACIN RESIDUES IN CHICKEN MEAT AND GIBLETS
Bulgarian Journal of Veterinary Medicine (2013), 16, Suppl. 1, 216 219 LEVOFLOXACIN RESIDUES IN CHICKEN MEAT AND GIBLETS R. KYUCHUKOVA 1, V. URUMOVA 2, M. LYUTSKANOV 2, V. PETROV 2 & A. PAVLOV 1 1 Department
More informationBurn Infection & Laboratory Diagnosis
Burn Infection & Laboratory Diagnosis Introduction Burns are one the most common forms of trauma. 2 million fires each years 1.2 million people with burn injuries 100000 hospitalization 5000 patients die
More informationAn evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage
Journal of Antimicrobial Chemotherapy (1991) 27, Suppl. C, 1-7 An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage J. J. Muscato",
More informationMarc Decramer 3. Respiratory Division, University Hospitals Leuven, Leuven, Belgium
AAC Accepts, published online ahead of print on April 0 Antimicrob. Agents Chemother. doi:./aac.0001- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationReduce the risk of recurrence Clear bacterial infections fast and thoroughly
Reduce the risk of recurrence Clear bacterial infections fast and thoroughly Clearly advanced 140916_Print-Detailer_Englisch_V2_BAH-05-01-14-003_RZ.indd 1 23.09.14 16:59 In bacterial infections, bacteriological
More informationRecommended for Implementation at Step 7 of the VICH Process on 15 December 2004 by the VICH Steering Committee
VICH GL27 (ANTIMICROBIAL RESISTANCE: PRE-APPROVAL) December 2003 For implementation at Step 7 - Final GUIDANCE ON PRE-APPROVAL INFORMATION FOR REGISTRATION OF NEW VETERINARY MEDICINAL PRODUCTS FOR FOOD
More informationComparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria
Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development
More informationMechanisms and Pathways of AMR in the environment
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationCarbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S
Carbapenemase-producing Enterobacteriaceae (CRE) T H E L A T E S T I N T H E G R O W I N G L I S T O F S U P E R B U G S CRE Enterobacteriaceae (Gram Negative Bacilli) Citrobacter species Escherichia coli***
More informationOvernight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients
TABLE 1. Origin and carbapenem resistance characteristics of the 64 Acinetobacter baumannii stock D-750 Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients
More informationDevelopment of Resistant Bacteria Isolated from Dogs with Otitis Externa or Urinary Tract Infections after Exposure to Enrofloxacin In Vitro
A. M. Brothers, P. S. Gibbs, and R. E. Wooley Development of Resistant Bacteria Isolated from Dogs with Otitis Externa or Urinary Tract Infections after Exposure to Enrofloxacin In Vitro Amy M. Brothers,
More informationConsequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of empiric antimicrobial therapy Increased number of hospitalizations Increased length
More informationAntimicrobial Resistance Acquisition of Foreign DNA
Antimicrobial Resistance Acquisition of Foreign DNA Levy, Scientific American Horizontal gene transfer is common, even between Gram positive and negative bacteria Plasmid - transfer of single or multiple
More informationMolecular Analysis of β-lactamase Genes in Antibiotic Resistant Bacteria
Bowling Green State University ScholarWorks@BGSU Honors Projects Honors College Spring 5-1-2017 Molecular Analysis of β-lactamase Genes in Antibiotic Resistant Bacteria Neisha Medina Candelaria neisham@bgsu.edu
More informationAntimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years
Journal of Antimicrobial Chemotherapy (2006) 57, 775 779 doi:10.1093/jac/dkl040 Advance Access publication 21 February 2006 Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the
More informationPrevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31
More informationOrigins of Resistance and Resistance Transfer: Food-Producing Animals.
Origins of Resistance and Resistance Transfer: Food-Producing Animals. Chris Teale, AHVLA. Origins of Resistance. Mutation Brachyspira hyodysenteriae and macrolide and pleuromutilin resistance. Campylobacter
More informationComparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys. Géza Sárközy
Comparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys Géza Sárközy Department of Pharmacology and Toxicology Faculty of Veterinary Science Szent István University
More informationMicrobiology : antimicrobial drugs. Sheet 11. Ali abualhija
Microbiology : antimicrobial drugs Sheet 11 Ali abualhija return to our topic antimicrobial drugs, we have finished major group of antimicrobial drugs which associated with inhibition of protein synthesis
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED
ESCHERICHIA COLI RESISTANCE AND GUT MICROBIOTA PROFILE IN PIGS RAISED WITH DIFFERENT ANTIMICROBIAL ADMINISTRATION IN FEED Caroline Pissetti 1, Jalusa Deon Kich 2, Heather K. Allen 3, Claudia Navarrete
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationSECTION 3A. Section 3A Criteria for Optional Special Authorization of Select Drug Products
SECTION 3A Criteria for Optional Special Authorization of Select Drug Products Section 3A Criteria for Optional Special Authorization of Select Drug Products CRITERIA FOR OPTIONAL SPECIAL AUTHORIZATION
More informationAntibiotics & Resistance
What are antibiotics? Antibiotics & esistance Antibiotics are molecules that stop bacteria from growing or kill them Antibiotics, agents against life - either natural or synthetic chemicals - designed
More informationAntibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?
Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? With the support of Wallonie-Bruxelles-International 1-1 In vitro evaluation of antibiotics : the antibiogram
More informationnumber Done by Corrected by Doctor Dr. Malik
number 25 Done by م ها أبو عجمي ة OsamsaAlZoubi Corrected by - Doctor Dr. Malik Antibiotic Misuse There are many ways of antibiotics misuse: Taking antibiotics when they are not needed: Antibiotics are
More informationCephalosporins, Quinolones and Co-amoxiclav Prescribing Audit
Cephalosporins, Quinolones and Co-amoxiclav Prescribing Audit Executive Summary Background Antibiotic resistance poses a significant threat to public health, as antibiotics underpin routine medical practice.
More informationMID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance
Antimicrobial Resistance Molecular Genetics of Antimicrobial Resistance Micro evolutionary change - point mutations Beta-lactamase mutation extends spectrum of the enzyme rpob gene (RNA polymerase) mutation
More informationDrug resistance in relation to use of silver sulphadiazine cream in a burns unit
J. clin. Path., 1977, 30, 160-164 Drug resistance in relation to use of silver sulphadiazine cream in a burns unit KIM BRIDGES AND E. J. L. LOWBURY From the MRC Industrial Injuries and Burns Unit, Birmingham
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationDANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme
DANMAP Danish Integrated Antimicrobial Resistance Monitoring and Research Programme Hanne-Dorthe Emborg Department of Microbiology and Risk Assessment National Food Institute, DTU Introduction The DANMAP
More informationThe First Report of CMY, AAC(6')-Ib and 16S rrna Methylase Genes among Pseudomonas aeruginosa Isolates from Iran
1 2 The First Report of CMY, AAC(6')-Ib and 16S rrna Methylase Genes among Pseudomonas aeruginosa Isolates from Iran Sedigheh Rafiei Tabatabaei, MD, MPH Associate Professor of Pediatric Infectious Diseases
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More informationProtocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland
Protocol for Surveillance of Antimicrobial Resistance in Urinary Isolates in Scotland Version 1.0 23 December 2011 General enquiries and contact details This is the first version (1.0) of the Protocol
More informationBiofilm eradication studies on uropathogenic E. coli using ciprofloxacin and nitrofurantoin
Available online at www.pharmscidirect.com Int J Pharm Biomed Res 212, 3(2), 127-131 Research article International Journal of PHARMACEUTICAL AND BIOMEDICAL RESEARCH ISSN No: 976-35 Biofilm eradication
More informationThe pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,
More informationR-factor mediated trimethoprim resistance: result of two three-month clinical surveys
Journal of Clinical Pathology, 1978, 31, 850-854 R-factor mediated trimethoprim resistance: result of two three-month clinical surveys S. G. B. AMYES1, A. M. EMMERSON2, AND J. T. SMITH3 From the 'Department
More informationINTRODUCTION. Wipawadee Sianglum 1, Wijit Wonglumsom 1, Potjanee Srimanote 2 and Kanokwan Kittiniyom 1
ANALYSIS OF GYRA MUTATIONS RELATED TO QUINOLONE RESISTANCE IN ESCHERICHIA COLI ISOLATES ORIGINATING FROM PET, HUMAN, VEGETABLE AND ICE IN BANGKOK AND VICINITY Wipawadee Sianglum 1, Wijit Wonglumsom 1,
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationDetection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 4008-4014 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.415
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT COLICEN 4.000.000 UI/ml solution for use in drinking water/milk 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains:
More informationMICROBIOLOGICAL AND EPIDEMIOLOGICAL INVESTIGATIONS AT THE VLA
CAMPYLOBACTER IN BROILERS IN UK: MICROBIOLOGICAL AND EPIDEMIOLOGICAL INVESTIGATIONS AT THE VLA J. Rodgers 1, L. Powell 2, F. Clifton-Hadley 1 and A. Vidal 1 1 Dept of Food and Environmental Safety 2 Centre
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationA review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe
Journal of Antimicrobial Chemotherapy (1991) 28, Suppl. C, 31-38 A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe F. Baqoero*, J. Martfnez-Beltran and E. Loza Servicio de
More informationInterpretative reading of the antibiogram. Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain
Interpretative reading of the antibiogram Luis Martínez-Martínez Service of Microbiology University Hospital Marqués de Valdecilla Santander, Spain ANTIBIOGRAM RESISTANCE SUSCEPTIBILITY ANTIMICROBIAL AGENT
More informationInfection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be
Gastrointestinal Infections Infection Comments First Line Agents Penicillin Allergy History of multiresistant Campylobacter Antibiotics not recommended. Erythromycin 250mg PO 6 Alternative to first N/A
More informationWhat do we know about multidrug resistant bacteria in New Zealand s pet animals?
What do we know about multidrug resistant bacteria in New Zealand s pet animals? Eve Pleydell Animal and Marine Biosecurity Response Team, Ministry for Primary Industries Formerly: Institute of Veterinary,
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY
More informationETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae
ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae Thomas Durand-Réville 02 June 2017 - ASM Microbe 2017 (Session #113) Disclosures Thomas Durand-Réville: Full-time Employee; Self;
More informationPROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains
PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...
More informationRelationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae
Journal of Antimicrobial Chemotherapy (2004) 54, 173 177 DOI: 10.1093/jac/dkh282 Advance Access publication 18 May 2004 Relationship between ceftriaxone use and resistance to third-generation cephalosporins
More informationInternational Food Safety Authorities Network (INFOSAN) Antimicrobial Resistance from Food Animals
International Food Safety Authorities Network (INFOSAN) 7 March 2008 INFOSAN Information Note No. 2/2008 - Antimicrobial Resistance Antimicrobial Resistance from Food Animals SUMMARY NOTES Antimicrobial
More informationORIGINAL ARTICLE /j x. University, Göteborg, Sweden
ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.01002.x Antibiotic resistance in Staphylococcus aureus colonising the intestines of Swedish infants E. Lindberg 1,2, I. Adlerberth 1 and A. E. Wold 1 1 Department
More informationInfection control: Need for robust guidelines
Infection control: Need for robust guidelines Hans Jørn Kolmos MD DMSc Professor, consultant Department of Clinical Microbiology Odense University Hospital hans.joern.kolmos@ouh.regionsyddanmark.dk Combating
More informationAabo, Søren; Ricci, Antonia; Denis, Martine; Bengtsson, Björn; Dalsgaard, Anders; Rychlik, Ivan; Jensen, Annette Nygaard
Downloaded from orbit.dtu.dk on: Sep 04, 2018 SafeOrganic - Restrictive use of antibiotics in organic animal farming a potential for safer, high quality products with less antibiotic resistant bacteria
More informationGeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007
GeNei Bacterial Antibiotic Sensitivity Teaching Kit Manual Cat No. New Cat No. KT68 106333 Revision No.: 00180705 CONTENTS Page No. Objective 3 Principle 3 Kit Description 4 Materials Provided 5 Procedure
More informationClinical Center of Microbiology Research, Ilam University of Medical Sciences, Ilam, Iran b
Mædica - a Journal of Clinical Medicine MAEDICA a Journal of Clinical Medicine 2014; 9(2): 162-167 ORIGINAL PAPERS Detection of Highly Ciprofloxacin Resistance Acinetobacter Baumannii Isolated from Patients
More informationGyrA Mutations in Nosocomial Ciprofloxacin-Resistant Escherichia coli Isolates Associated with Urinary Tract Infections
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 2 (2017) pp. 1902-1907 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2017.602.215
More informationInt.J.Curr.Microbiol.App.Sci (2018) 7(8):
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378
More informationResearch Article Faecal Carriage of Extended-Spectrum ß-Lactamase (ESBL)- Producing Aeromonas species
Cronicon OPEN ACCESS MICROBIOLOGY Research Article Faecal Carriage of Extended-Spectrum ß-Lactamase (ESBL)- Producing Aeromonas species Aurora Longa B 1, Judith Velasco 1, Génesis Camacho D 1, Dalierys
More informationCentral Ohio Primary Care and Local Specialty Group Working Hand in Glove for Better Patient Outcomes!
Central Ohio Primary Care and Local Specialty Group Working Hand in Glove for Better Patient Outcomes! Rebecca Burk BS(QSM), Laboratory Manager, Central Ohio Primary Care Physicians, Inc. Contributing
More informationINCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS
INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS 1 Research Associate, Drug Utilisation Research Unit, Nelson Mandela University 2 Human Sciences Research Council,
More informationInternational Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.
I J A P B International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access. ISSN: 2454-8375 COMPARISON OF ANTIMICROBIAL ACTIVITY AND MIC OF BRANDED
More informationProject Summary. Principal Investigators: Ross Beier 1, T. Poole 1, Dayna Harhay 2, and Robin Anderson 1 1
Project Summary Antibiotic and Disinfectant Susceptibility Profiles of Escherichia coli O157:H7 Cattle Feces, Hide, Carcass, and Ground Meat Isolates from the United States Principal Investigators: Ross
More informationEUCAST Expert Rules for Staphylococcus spp IF resistant to isoxazolylpenicillins
EUAST Expert Rules for 2018 Organisms Agents tested Agents affected Rule aureus Oxacillin efoxitin (disk diffusion), detection of meca or mec gene or of PBP2a All β-lactams except those specifically licensed
More informationAntibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents
Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More informationAntimicrobial Resistance
Antimicrobial Resistance Consequences of Antimicrobial Resistant Bacteria Change in the approach to the administration of Change in the approach to the administration of empiric antimicrobial therapy Increased
More informationAntibiotic Prophylaxis Update
Antibiotic Prophylaxis Update Choosing Surgical Antimicrobial Prophylaxis Peri-Procedural Administration Surgical Prophylaxis and AMS at Epworth HealthCare Mr Glenn Valoppi Dr Trisha Peel Dr Joseph Doyle
More informationRandall Singer, DVM, MPVM, PhD
ANTIBIOTIC RESISTANCE Randall Singer, DVM, MPVM, PhD Associate Professor of Epidemiology Department of Veterinary and Biomedical Sciences University of Minnesota Overview How does resistance develop? What
More information11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1
Disclosures Selecting Antimicrobials for Common Infections in Children FMR-Contemporary Pediatrics 11/2016 Sean McTigue, MD Assistant Professor of Pediatrics, Pediatric Infectious Diseases Medical Director
More information